Thermo Fisher Scientific Inc. (TMO) is slated to release first-quarter 2024 results on Apr 24, 2024, before market open.Thermo Fisher’s earnings of $5.67 per share in the last reported quarter topped the Zacks Consensus Estimate by 0.5%. Its earnings surpassed estimates in three of the trailing four quarters, the average negative surprise being 0.26%.Let's discuss the factors that are likely to be reflected in the upcoming results.Factors at PlayThermo Fisher’s Analytical Instruments segment is expected to ...

Thermo Fisher (NYSE:TMO) layoffs are in the news Tuesday after the biopharma services company announced job cuts at its California plasmid manufacturing location.According to these latest reports, Thermo Fisher is going to cut 74 jobs from the facility starting May 31, 2024. The layoffs are part of the company’s efforts to adjust staffing levels at the manufacturing plant.Thermo Fisher has confirmed the layoffs in a statement to Fierce Pharma. In it a company spokesperson noted that there are “times when we ...

Thermo Fisher Scientific (TMO) recently introduced the TSX Universal Series ultra-low temperature (ULT) freezers with enhanced performance, user experience and energy efficiency. The new line of high-performance freezers seamlessly adapts to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability and sustainability.The latest development from Thermo Fisher builds on 80 years of expertise in engineering cold storage lab equipment. The company continues to support ...

Thermo Fisher Scientific (TMO) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this maker of scientific instrument and laboratory supplies have returned -2.6% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Medical - Instruments industry, to which Thermo Fisher belongs, has lost 0.3% over this period. Now the key question is: Where coul ...

Thermo Fisher Scientific (TMO) recently announced the introduction of its new metrology solution — the Thermo Scientific LInspector Edge In-line Mass Profilometer. Designed to address the needs of the rapidly growing battery market, the device delivers full-width electrode mass loading measurement and provides battery manufacturers with the data needed to make better, safer batteries more efficiently.The new LInspector Edge In-line Mass Profilometer represents the first in a new generation of battery proces ...

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $580.05, marking a -0.46% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.89%. Meanwhile, the Dow gained 1.03%, and the Nasdaq, a tech-heavy index, added 1.25%.Shares of the maker of scientific instrument and laboratory supplies have appreciated by 6.31% over the course of the past month, outperforming the Medical sector's gain of 0.72% and the S&P 500's gain of 3.56%.Investors will be eager ...

Thermo Fisher Scientific (TMO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Shares of this maker of scientific instrument and laboratory supplies have returned +8.2% over the past month versus the Zacks S&P 500 composite's +4.4% change. The Zacks Medical - Instruments industry, to which Thermo Fisher belongs, has gained 6.2% over this period. Now the key questio ...

In the latest market close, Thermo Fisher Scientific (TMO) reached $597.25, with a -0.36% movement compared to the previous day. This change lagged the S&P 500's daily gain of 1.12%. Meanwhile, the Dow experienced a rise of 0.61%, and the technology-dominated Nasdaq saw an increase of 1.54%.Shares of the maker of scientific instrument and laboratory supplies have appreciated by 9.61% over the course of the past month, outperforming the Medical sector's gain of 2.49% and the S&P 500's gain of 2.06%.The inves ...

Thermo Fisher Scientific (TMO) announced the launch of a new CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP). The new registry, which is open to enrollment, is CorEvitas’ 10th syndicated disease registry and addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP.For investors’ note, Thermo Fisher’s August 2021 acquisition of CorEvitas has expanded the company’s Laboratory Products and Biopharma Services segmen ...

The latest trading session saw Thermo Fisher Scientific (TMO) ending at $591.50, denoting a +1.18% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 0.51%. Meanwhile, the Dow experienced a rise of 0.2%, and the technology-dominated Nasdaq saw an increase of 0.58%.The maker of scientific instrument and laboratory supplies's shares have seen an increase of 4.34% over the last month, surpassing the Medical sector's gain of 2.54% and the S&P 500's gain of 2.94%.Analysts and in ...